陈列
发表于 2025-4-1 05:31:02
http://reply.papertrans.cn/88/8773/877221/877221_61.png
阉割
发表于 2025-4-1 07:27:38
Changing the Course of Peripheral Arterial Disease Using Adult Stem Progenitor Cells,tion) are transformed, within a day, into a therapeutic product (BGC101) composed of endothelial progenitor cells (EPCs), SPCs, dendritic cells (DCs), and T helper cells. BGC101 was found safe and effective in stabilizing and reversing the course of CLI. Controlled studies on a larger population are
Muscularis
发表于 2025-4-1 10:36:56
Stem Cell Delivery for the Treatment of Arteriovenous Fistula Failure, a great deal of work aimed at reducing and preventing fistula failure with some benefit. Despite these advances, fistula failure remains a significant problem as only about 60% of fistulas remain patent at one year (Al-Jaishi et al., Am J Kidney Dis 63:464–478, 2014)..Mesenchymal stem cells are plu